Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Exploratory outcomes included changes in waist circumference, systolic-type blood pressure, and NT-proBNP levels
Disclosure and Compliance Information Material Limitations
use within 30 days
According to the drug label, Wegovy is contraindicated (should not be used) in the following populations: Individuals with a known sensitivity to semaglutide or other ingredients in Wegovy Individuals with a personal or family medical history of medullary thyroid cancer (MTC) Individuals with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Wegovy is also not approved for use in pediatric patients under 12 years old or pregnant people
Physicians in charge decided plasma sampling to measure plasma VPA concentrations, treatments and L-carnitine dose regimen, which included an intravenous 100 mg/kg loading dose followed by a maintenance dosing up to 3 g/day in 3 divided doses for 3 days (or until ICU discharge)
